Farmacología y Toxicología
Département
![Foto de Farmacología y Toxicología](/img/uploaded/23E83769E728F6DD105AA7DD88F74397.jpg)
![Foto de University of Hertfordshire](/img/noimage_org.png)
University of Hertfordshire
Hatfield, Reino UnidoPublications en collaboration avec des chercheurs de University of Hertfordshire (9)
2021
-
Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention
International Journal of Cardiology, Vol. 337, pp. 1-8
2008
-
Aliskiren - The first of a new class of antihypertensive
Drugs in Context, Vol. 4, Núm. 1, pp. 105-120
-
Cervarix - Preventing cervical cancer and other diseases related to HPV
Drugs in Context, Vol. 4, Núm. 1, pp. 59-70
-
Coversyl Plus - Treating hypertension and improving clinical outcomes in T2D and other high risk groups
Drugs in Context, Vol. 4, Núm. 1, pp. 71-84
-
Ezetimibe - A clinically effective and a cost-effective treatment option for dyslipidaemia
Drugs in Context, Vol. 4, Núm. 1, pp. 85-104
-
Gardasil - Preventing cervical cancer and other diseases related to HPV
Drugs in Context, Vol. 4, Núm. 1, pp. 29-40
-
Inegy - Effective combination treatment to target LDL-C levels
Drugs in Context, Vol. 4, Núm. 1, pp. 41-58
-
Telmisartan - An effective antihypertensive for 24-hour blood pressure control
Drugs in Context, Vol. 4, Núm. 1, pp. 1-14
-
Tiotropium - Advancing the treatment of COPD
Drugs in Context, Vol. 4, Núm. 1, pp. 15-28